- Report
- November 2021
Asia Pacific
From €12821EUR$14,500USD£10,938GBP
- Report
- November 2021
Global
From €30504EUR$34,500USD£26,026GBP
- Book
- June 2024
- 496 Pages
- Book
- April 2024
- 448 Pages
- Book
- April 2023
- 176 Pages
- Book
- September 2022
- 304 Pages
- Book
- January 2022
- 720 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- January 2019
- 264 Pages
- Book
- January 2019
- 600 Pages
- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- May 2014
- 560 Pages
- Book
- April 2014
- 344 Pages
- Book
- November 2013
- 744 Pages
- Book
- April 2013
- 296 Pages
- Book
- November 2012
- 240 Pages

The Coagulation market within the context of Biotechnology is a rapidly growing sector that focuses on the development of products and services related to the diagnosis and treatment of blood clotting disorders. These products and services are used to diagnose and treat a variety of conditions, including hemophilia, thrombosis, and other bleeding disorders. The market is driven by the increasing prevalence of these disorders, as well as the development of new technologies and treatments.
The Coagulation market is composed of a variety of companies, including those that develop and manufacture products, such as reagents, instruments, and consumables, as well as those that provide services, such as clinical testing and consulting. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. Show Less Read more